相关实验视频

Updated: Jun 17, 2025

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

探索集群定期间隔的短Palindromic重复-CRISPR相关蛋白9 (CRISPR-Cas9) 作为癌症的治疗方式:一个范围审查

Abirami Balasubramanian¹, Keerthana Veluswami¹, Sudipta Rao²

¹Internal Medicine, Stanley Medical College, Chennai, IND.

|August 12, 2024

概括

聚类定期间隔的短平行体重复-CRISPR相关蛋白9 (CRISPR-Cas9) 基因编辑通过精确向癌细胞,为癌症治疗提供了一种强大的新方法. 虽然有前途,但像分娩和非目标效应这样的挑战需要进一步的研究才能有效地临床应用.

科学领域:

分子生物学分子生物学
遗传学遗传学是一个
在瘤学瘤学.

背景情况:

全球癌症负担需要新的治疗策略.
传统的癌症治疗方法在有效性和特异性方面存在局限性.
克里斯普尔-Cas9技术为癌症治疗带来了潜在的范式转变.

研究的目的:

审查CRISPR-Cas9在癌症治疗中的机制和应用.
探索CRISPR-Cas9比其他基因编辑工具的优势.
讨论与CRISPR-Cas9在瘤学中的挑战和伦理考虑.

主要方法:

研究了CRISPR-Cas9.9的分子机制.
审查了关于CRISPR-Cas9在癌症治疗中的应用研究.
分析了CRISPR-Cas9在基因淘汰,代谢干扰,基因编辑,查和免疫疗法增强方面的有效性.
将CRISPR-Cas9与其他核酶 (ZFN,TALEN) 进行比较.

主要成果:

克里斯普尔-Cas9可以为癌症治疗提供精确的基因编辑.
在各种治疗策略中证明有效,包括免疫疗法增强.
突出了CRISPR-Cas9在指核酶和转录激活器类效应核酶上的优势.
确定了关键挑战:非目标效应,交付效率和新出现的阻力.

结论:

克里斯普尔-Cas9对重塑癌症治疗模式具有重大前景.
需要进一步的研究来克服临床翻译的技术和伦理障碍.
克里斯普尔-Cas9为开发下一代癌症疗法提供了一个多功能平台.

关键词:

最先进的治疗方法是先进的治疗方法.癌症癌症癌症癌症癌症癌症免疫疗法免疫疗法这就是Crispr Cas9的原因.克里斯普-卡斯-卡斯的情况直接基础编辑直接基础编辑基因组编辑基因组编辑瘤学在瘤学方面.

更多相关视频

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...